NCT06606704 Effects of Resistance-band Training and Creatine Supplementation Strategies in Healthy Older Adults
| NCT ID | NCT06606704 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Regina |
| Condition | Aging |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2024-08-20 |
| Primary Completion | 2025-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2024-08-20 with a primary completion date of 2025-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary purpose is to compare the effects of creatine supplementation (bolus ingestion of 5 grams vs. 3 grams) during 16 weeks of resistance-band training on measures of body composition (i.e., whole-body lean tissue mass, total body water), arm and leg muscle thickness (growth), muscle performance (i.e., power, strength, endurance) and functional ability (i.e., walking speed, balance). A secondary purpose of this research is to examine the effects of bolus ingestion of creatine (5 grams) compared to intermittent ingestion of creatine (2 x 2.5 grams) during 16 weeks of resistance-band training on measures of body composition (i.e., whole-body lean tissue mass, total body water), arm and leg muscle thickness (growth), muscle performance (i.e., power, strength, endurance) and functional ability (i.e., walking speed, balance).
Eligibility Criteria
Inclusion Criteria: * if you are 50 years of age and older * if you have not been performing more than 1 resistance training session per week for the past 6 weeks or more. Exclusion Criteria: * if you have taken creatine supplements within 30 days prior to the start of the study * if you have pre-existing allergies to the placebo (corn-starch maltodextrin).
Contact & Investigator
Darren Candow
PRINCIPAL INVESTIGATOR
University of Regina
Frequently Asked Questions
Who can join the NCT06606704 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06606704 currently recruiting?
Yes, NCT06606704 is actively recruiting participants. Contact the research team at Darren.Candow@uregina.ca for enrollment information.
Where is the NCT06606704 trial being conducted?
This trial is being conducted at Regina, Canada.
Who is sponsoring the NCT06606704 clinical trial?
NCT06606704 is sponsored by University of Regina. The principal investigator is Darren Candow at University of Regina. The trial plans to enroll 52 participants.